Efficacy and safety of bifeprunox in patients with an acute exacerbation of schizophrenia: results from a randomized, double-blind, placebo-controlled, multicenter, dose-finding study.
about
Bifeprunox versus placebo for schizophreniaEvaluation of the clinical efficacy of asenapine in schizophreniaBrexpiprazole: so far so goodUpdate on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor AntagonismDopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and FuturePaliperidone ER and oral risperidone in patients with schizophrenia: a comparative database analysisComparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties.Quantitative systems pharmacology as an extension of PK/PD modeling in CNS research and development.Investigational drugs for schizophrenia targeting the dopamine receptor: phase II trials.Newer molecules in the treatment of schizophrenia: A clinical updateThird generation antipsychotic drugs: partial agonism or receptor functional selectivity?Targeting the dopamine receptor in schizophrenia: investigational drugs in Phase III trials.Aripiprazole and Haloperidol Activate GSK3β-Dependent Signalling Pathway Differentially in Various Brain Regions of Rats.Chronic administration of aripiprazole activates GSK3β-dependent signalling pathways, and up-regulates GABAA receptor expression and CREB1 activity in ratsDrugs in development for the treatment of schizophrenia.Dose equivalents for second-generation antipsychotics: the minimum effective dose method.Emerging drugs for schizophrenia.The preclinical profile of brexpiprazole: what is its clinical relevance for the treatment of psychiatric disorders?Bifeprunox versus placebo for schizophrenia.Not all partial dopamine D(2) receptor agonists are the same in treating schizophrenia. Exploring the effects of bifeprunox and aripiprazole using a computer model of a primate striatal dopaminergic synapse.The Black Book of Psychotropic Dosing and Monitoring.Adjunctive brexpiprazole for the treatment of major depressive disorder.Aripiprazole Increases the PKA Signalling and Expression of the GABAA Receptor and CREB1 in the Nucleus Accumbens of Rats.
P2860
Q24186774-4B1D5BC7-8197-41F7-A1F3-B556C82F2759Q24630385-714B0FFD-DFA7-4C0A-94F6-CB5A4D20DC78Q26766401-3041A7F0-C166-4BE9-8AB3-655160604BF9Q28084069-30685DC4-F1A0-42BF-B9EB-99D5ABF61611Q28394341-DC9593D9-0350-42EF-A8FC-AC3FBC105776Q30998569-9A4571CD-EE57-440A-A571-F7D50F0F263FQ34169978-627AAA6E-8453-4D96-9780-80209800D275Q34323711-C32E783F-D40E-4AA9-A135-47546DEECEE3Q34703195-3946A436-CB35-4FAD-8036-05AD95432E4DQ34843883-E35D2BBD-245A-477E-94FD-69F53851C6E1Q35012574-5BD7BD37-0F88-4B35-BD46-1CFA94A794E2Q35071909-FCE4AD7F-1E1A-4C9C-80B7-D8D4BD1FF350Q36846918-98BCA03E-F973-4BD9-87B1-C912CF70F14BQ37111054-E4826073-66F5-47D4-AE5F-C1FA051F7328Q37546125-110E4375-95B4-4951-ABE7-50909BEE0008Q37598284-20FB71E0-FB82-4CA1-A173-C59A699A46F4Q37874626-5F63A791-3540-4AB0-AFA5-F29CBBC2B2F5Q38592139-560907A7-9AC2-4978-9313-C1F4A97DDE94Q38978909-F66B213D-72DE-4BA8-84AE-CE390D13521BQ41918764-3566A744-DA78-49B9-A0C0-E8140FB9BB84Q47642128-59CFB1A0-F95C-40A3-8FBB-883A25A6E806Q48037953-6245B281-4CC1-42BE-9AAC-449411009E11Q48234174-7A12A6E4-0396-4A74-9018-B937FD77BB59
P2860
Efficacy and safety of bifeprunox in patients with an acute exacerbation of schizophrenia: results from a randomized, double-blind, placebo-controlled, multicenter, dose-finding study.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Efficacy and safety of bifepru ...... lticenter, dose-finding study.
@ast
Efficacy and safety of bifepru ...... lticenter, dose-finding study.
@en
Efficacy and safety of bifepru ...... lticenter, dose-finding study.
@nl
type
label
Efficacy and safety of bifepru ...... lticenter, dose-finding study.
@ast
Efficacy and safety of bifepru ...... lticenter, dose-finding study.
@en
Efficacy and safety of bifepru ...... lticenter, dose-finding study.
@nl
prefLabel
Efficacy and safety of bifepru ...... lticenter, dose-finding study.
@ast
Efficacy and safety of bifepru ...... lticenter, dose-finding study.
@en
Efficacy and safety of bifepru ...... lticenter, dose-finding study.
@nl
P2093
P2860
P921
P1433
P1476
Efficacy and safety of bifepru ...... lticenter, dose-finding study.
@en
P2093
Daniel E Casey
Earl E Sands
Hwa-Ming Yang
Jens Heisterberg
P2860
P2888
P304
P356
10.1007/S00213-008-1207-7
P577
2008-07-04T00:00:00Z
P6179
1032631655